Stay updated on Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page.

Latest updates to the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedSite revision updated to v3.4.2. The previous administrative notes, including the lapse in government funding notice and the v3.4.1 revision, were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding status and the NIH Clinical Center's openness was added, and the revision note was updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary toggle (Show glossary) and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data). A new site revision note (Revision: v3.4.0) was introduced.SummaryDifference0.2%

- Check42 days agoChange DetectedThe only change is the revision from v3.3.3 to v3.3.4; no substantive content about the study details, eligibility, or locations was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedFooter now displays 'Revision: v3.3.3' and the links 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page.